LOGIN
ID
PW
MemberShip
2024-09-19 17:32
All News
Policy
Company
Product
Opinion
InterView
검색
Dailypharm Live Search
Close
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
Input Time : 2019-12-23
[Download file]
go back
OPINION
[Reporter’s View] The new drug approval fee hike
Reporter's view |
Lee, Hye-Kyung
[Reporter’s View] Benefits of the U.S. Biosecure Act
Reporter's view |
Son, Hyung Min
[Reporter's View] ‘Tyranny of Drug Committees persist'
Reporter's view |
Eo, Yun-Ho
INTERVIEW
‘Era of once-weekly growth hormones…adherence is key’
Masanobu Kawai, Professor at Osaka Women's and Children's Hospital
"New targeted therapies for bile duct cancer are in need"
AstraZeneca seeks mutual growth through open collaboration
with Korea’s pharmaceutical industry
‘We need to actively use acetaminophen ER tablets'
‘Ireland, a bridgehead for companies entering the EU mkt'
Rory Mullen, Global Head of Biopharma and Food at Investment Promotion & Development Agency Ireland
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
Reimb for orphan drug 'Welireg' for cancer has been denied
2
Samsung Bioepis recruits Lina Choi as new global head
3
Will Columvi be reviewed for reimb by CDDC in OCT?
4
[Reporter’s View] The new drug approval fee hike
5
MFDS approves Hemgenix for Hemophilia B in Korea
